PETIn vivo · the living brain
PET
- Measures
- Where a radiolabelled tracer goes in the living brain, over time. With kinetic modelling, that becomes a quantitative measure of binding to a target.
- Strength
- Non-invasive and repeatable in the same animal — before and after treatment, or as disease develops. The same method is used in people.
- Alone, can't
- Resolve fine anatomical detail, or say which cellular change lies behind a change in binding.
[11C]yohimbine VT maps in a minipig at baseline and after nisoxetine, a drug that raises noradrenaline. Landau et al., Biomolecules 2023 · doi:10.3390/biom13040674 · CC BY 4.0, cropped.
![Four coronal rat brain autoradiograms of [3H]UCB-J binding at striatal level, arranged saline versus 6-OHDA and sedentary versus exercised, with dashed circles over the left and right striatum.](/assets/figures/binda2021-expneurol-fig4a.jpg)
